https://us.efferon.com/ 2026-04-22 weekly 1 https://us.efferon.com/about 2026-06-15T10:53:24.522Z monthly 0.7 https://us.efferon.com/technology 2026-06-15T10:53:24.522Z monthly 0.8 https://us.efferon.com/indications 2026-06-15T10:53:24.522Z monthly 0.8 https://us.efferon.com/news 2026-04-22 weekly 0.7 https://us.efferon.com/articles 2026-06-15T10:53:24.522Z monthly 0.7 https://us.efferon.com/products/efferon-lps 2026-06-15T10:53:24.522Z monthly 0.9 https://us.efferon.com/products/efferon-neo 2026-06-15T10:53:24.522Z monthly 0.9 https://us.efferon.com/news/efferonneo-receives-ce-mdr-mark 2026-04-22 yearly 0.6 https://us.efferon.com/news/efferon-at-isicem 2026-04-10 yearly 0.6 https://us.efferon.com/news/efferon-first-distributors-meeting 2026-04-08 yearly 0.6 https://us.efferon.com/news/efferon-is-now-available-in-poland 2026-03-11 yearly 0.6 https://us.efferon.com/news/efferonlps-is-available-in-costa-rica 2026-02-26 yearly 0.6 https://us.efferon.com/news/efferon-lps-is-now-approved-in-thailand 2026-02-18 yearly 0.6 https://us.efferon.com/news/efferon-lps-incorporated-into-clinical-guidelines-of-the-german-society-of-nephrology-for-therapeutic-apheresis 2025-12-10 yearly 0.6 https://us.efferon.com/news/well-see-each-other-in-greece 2025-11-25 yearly 0.6 https://us.efferon.com/news/efferon-therapies-are-now-available-in-armenia 2025-11-05 yearly 0.6 https://us.efferon.com/news/clinical-data-confirmed-the-effectiveness-of-efferon-neo-in-children-with-sepsis 2025-10-30 yearly 0.6 https://us.efferon.com/news/efferon-lps-has-been-approved-in-the-kingdom-of-saudi-arabia 2025-10-18 yearly 0.6 https://us.efferon.com/news/extracorporeal-removal-of-antibiotic-drugs-during-efferon-lps-hemoadsorption-is-predictable-and-manageable 2025-10-09 yearly 0.6 https://us.efferon.com/news/efferon-at-the-6th-asia-pacific-aki-crrt-congress-in-bangkok 2025-10-05 yearly 0.6 https://us.efferon.com/news/win-a-new-ipad-join-the-efferon-lps-photo-challenge-on-linkedin 2025-09-12 yearly 0.6 https://us.efferon.com/news/efferon-lps-hemoadsorption-device-has-been-granted-regulatory-approval-in-the-united-kingdom-and-croatia 2025-07-23 yearly 0.6 https://us.efferon.com/news/efferon-lps-now-available-in-italy 2025-07-01 yearly 0.6 https://us.efferon.com/news/applying-vicenzas-lessons 2025-06-28 yearly 0.6 https://us.efferon.com/news/efferon-expands-its-global-presence 2025-06-23 yearly 0.6 https://us.efferon.com/news/efferon-expands-to-new-markets-with-bertossi-partnership 2025-06-06 yearly 0.6 https://us.efferon.com/news/efferon-lps-becomes-available-in-romania 2025-05-25 yearly 0.6 https://us.efferon.com/news/distribution-agreements-in-european-countries 2024-07-22 yearly 0.6 https://us.efferon.com/news/efferon-lps-receives-ce-mark-under-eu-mdr 2024-04-29 yearly 0.6 https://us.efferon.com/news/pub20 2023-04-20 yearly 0.6 https://us.efferon.com/news/pub19 2022-11-03 yearly 0.6 https://us.efferon.com/news/pub17 2021-11-30 yearly 0.6 https://us.efferon.com/news/pub10 2021-04-29 yearly 0.6 https://us.efferon.com/articles/eferon-lps-neo-hemoadsorption-in-pediatric-sepsis-patients-a-multicenter-controlled-study 2025-01-01 yearly 0.5 https://us.efferon.com/articles/multimodal-lps-selective-hemoadsorption-combined-with-hemodiafiltration-in-the-intensive-care-of-gram-negative-sepsis-a-multicenter-observational-study 2025-01-01 yearly 0.5 https://us.efferon.com/articles/pub23 2024-01-01 yearly 0.5 https://us.efferon.com/articles/pub22 2023-01-01 yearly 0.5 https://us.efferon.com/articles/extracorporeal-hemoperfusion-with-efferon-lps-for-rapid-reconstitution-of-vital-parameters-and-decreasing-proinflammatory-biomarkers-in-patients-with-intra-abdominal-sepsis 2022-01-01 yearly 0.5 https://us.efferon.com/articles/pub8 2021-01-01 yearly 0.5 https://us.efferon.com/articles/pub9 2021-01-01 yearly 0.5 https://us.efferon.com/articles/pub6 2020-01-01 yearly 0.5 https://us.efferon.com/articles/pub7 2020-01-01 yearly 0.5 https://us.efferon.com/articles/pub5 2018-01-01 yearly 0.5 https://us.efferon.com/articles/pub1 2017-01-01 yearly 0.5 https://us.efferon.com/articles/pub2 2017-01-01 yearly 0.5 https://us.efferon.com/articles/pub3 2017-01-01 yearly 0.5 https://us.efferon.com/articles/pub4 2016-01-01 yearly 0.5